Shree Ganesh [SGRL] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Shree Ganesh Remedies Ltd.

BSE
Loading...

Sun Pharma Advanced Research Company Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Shree Ganesh Remedies Ltd. wins in 15 metrics, Sun Pharma Advanced Research Company Ltd. wins in 3 metrics, with 0 ties. Shree Ganesh Remedies Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Shree Ganesh Remedies Ltd. Sun Pharma Advanced Research Company Ltd. Better
P/E Ratio (TTM) 37.03 -13.65 Shree Ganesh Remedies Ltd.
Price-to-Book Ratio 4.36 -13.55 Shree Ganesh Remedies Ltd.
Debt-to-Equity Ratio 24.45 -1.21 Shree Ganesh Remedies Ltd.
PEG Ratio -0.86 -11.15 Shree Ganesh Remedies Ltd.
EV/EBITDA 18.54 -22.27 Shree Ganesh Remedies Ltd.
Profit Margin (TTM) 17.99% -53.22% Shree Ganesh Remedies Ltd.
Operating Margin (TTM) 19.25% -700.71% Shree Ganesh Remedies Ltd.
EBITDA Margin (TTM) 19.25% N/A N/A
Return on Equity 15.89% 157.88% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) 12.02% -102.08% Shree Ganesh Remedies Ltd.
Free Cash Flow (TTM) $74.69M $-3.71B Shree Ganesh Remedies Ltd.
1-Year Return -2.45% 34.88% Sun Pharma Advanced Research Company Ltd.
Price-to-Sales Ratio (TTM) 6.66 87.98 Shree Ganesh Remedies Ltd.
Enterprise Value $6.74B $50.87B Sun Pharma Advanced Research Company Ltd.
EV/Revenue Ratio 6.70 95.73 Shree Ganesh Remedies Ltd.
Gross Profit Margin (TTM) 70.00% -59.53% Shree Ganesh Remedies Ltd.
Revenue per Share (TTM) $78 $2 Shree Ganesh Remedies Ltd.
Earnings per Share (Diluted) $14.09 $-8.25 Shree Ganesh Remedies Ltd.
Beta (Stock Volatility) 0.19 0.19 Shree Ganesh Remedies Ltd.

Shree Ganesh Remedies Ltd. vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis

Loading Price Chart...

SGRL
SPARC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Shree Ganesh Remedies Ltd.-5.26%-12.23%-1.17%19.76%24.86%27.80%
Sun Pharma Advanced Research Company Ltd.2.36%12.49%39.95%100.62%67.89%69.61%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Shree Ganesh Remedies Ltd.-2.45%64.10%49.51%1,719.55%1,719.55%1,719.55%
Sun Pharma Advanced Research Company Ltd.34.88%14.54%-3.55%-20.47%148.26%-23.02%

Performance & Financial Health Analysis: Shree Ganesh Remedies Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricSGRLSPARC
Market Information
Market Cap i₹6.70B₹46.75B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i4,4882,401,062
90 Day Avg. Volume i4,5362,083,443
Last Close₹568.85₹229.03
52 Week Range₹381.10 - ₹665.00₹108.00 - ₹248.75
% from 52W High-14.46%-7.93%
All-Time High₹950.05 (Jul 22, 2024)₹875.00 (Apr 24, 2006)
% from All-Time High-40.12%-73.83%
Growth Metrics
Quarterly Revenue Growth-0.22%-0.43%
Quarterly Earnings Growth-0.43%-0.43%
Financial Health
Profit Margin (TTM) i0.18%-0.53%
Operating Margin (TTM) i0.19%-7.01%
Return on Equity (TTM) i0.16%1.58%
Debt to Equity (MRQ) i24.45-1.21
Cash & Liquidity
Book Value per Share (MRQ)₹119.59₹-10.63
Cash per Share (MRQ)₹26.25₹0.03
Operating Cash Flow (TTM) i₹337.14M₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹230.68M₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i₹0.00N/A

Valuation & Enterprise Metrics Analysis: Shree Ganesh Remedies Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricSGRL (Apr 24, 2026)SPARC (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i37.03-13.65
Forward P/E iN/A2.60
PEG Ratio i-0.86-11.15
Price to Sales (TTM) i6.6687.98
Price to Book (MRQ) i4.36-13.55
Market Capitalization
Market Capitalization i₹6.70B₹46.75B
Enterprise Value i₹6.74B₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i6.7095.73
Enterprise to EBITDA i18.54-22.27
Risk & Other Metrics
Beta i0.190.19
Book Value per Share (MRQ) i₹119.59₹-10.63

Financial Statements Comparison: Shree Ganesh Remedies Ltd. vs Sun Pharma Advanced Research Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSGRL (2025)SPARC (2025)
Revenue/Sales i1.07B717.66M
Cost of Goods Sold i361.73M1.10B
COGS % of Revenue i34.0%153.2%
Gross Profit i703.31M-381.94M
Gross Margin i66.0%-53.2%
Research & Development i2.65MN/A
Operating Income (EBIT) i301.91M-3.34B
Operating Margin i28.3%-465.5%
EBITDA i420.76M-3.23B
EBITDA Margin i39.5%-450.0%
Pre-Tax Income i312.68M-3.43B
Pre-Tax Income % of Revenue i29.4%-477.6%
Income Tax i81.99M-2.72M
Income Tax % of Revenue i7.7%-0.4%
Net Income (Profit) i230.68M-3.43B
Profit Margin i21.7%-477.3%

Balance Sheet & Liquidity Metrics

MetricSGRL (2025)SPARC (2025)
Cash & Equivalents i99.43M19.64M
Total Current Assets i775.75M261.97M
Total Current Assets % of Revenue i72.8%36.5%
Total Current Liabilities i161.82M3.74B
Total Current Liabilities % of Revenue i15.2%521.5%
Long-Term Debt i296.08M1.07B
Long-Term Debt % of Revenue i27.8%149.0%
Total Shareholders Equity i1.45B-2.17B
Retained Earnings i1.10B-23.22B
Retained Earnings % of Revenue i103.1%-3,235.0%
Property, Plant & Equipment i31.57M178.02M

Cash Flow Statement Comparison

MetricSGRL (2025)SPARC (2025)
Operating Cash Flow i337.14M-3.48B
Operating Cash Flow % of Revenue i31.7%-485.5%
Capital Expenditures i-231.76M-97.45M
Free Cash Flow i74.69M-3.71B
FCF Margin i7.0%-516.4%
Debt Repayment iN/A-3.69B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSGRLSPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i12.84M324.52M
Float Shares i3.09M91.32M
% Held by Insiders i75.92%72.96%
% Held by Institutions i0.00%2.56%
% Held by Public i24.08%24.48%

Dividend Analysis & Yield Comparison: Shree Ganesh Remedies Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricSGRLSPARC
Last 12-Month Dividend i₹0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i₹0.33N/A
3-Year Avg Dividend Yield i0.15%N/A
3-Year Total Dividends i₹1.00N/A
Ex-Dividend DateSep 07, 2023N/A